abcdefghijklmn
opqrstuvwxyz
Test Menu
Test Change Details
Allergy & Immunology
Cardiology & Coagulation
Dermatopathology
Endocrinology
Gastroenterology
Genetics
Hepatology
Infectious Disease
Microbiology
Nephrology
Neurology
Oncology
Pathology
Pediatrics
Rheumatology
Toxicology
Urology
Women's Health
91995: Colorectal Cancer, KRAS Mutation, Therascreen® Print View
KRAS Mutation Status      
KRAS Mutation ID      

PRIMARY
1 Tissue Paraffin Block   Refrigerated - 12 Month(s)/Room Temperature - 12 Month(s)  
ALTERNATE

The Therascreen(R) KRAS RGQ PCR kit is intended to aid in the identification of colorectal cancer patients for treatment with Erbitux(R) (cetuximab) based on a KRAS "No mutation detected" test result.

Regular procedure for paraffin-embedded tissue block preparation.
If frozen tissue block is received, call 1(800) 642-4657 ext. 2906.
Setup Schedule
Tuesday

Reported (Analytical Time)
4 days

CPT Code
81275

The CPT codes provided are based on AMA guidelines and are for informational purposes only. CPT coding is the sole responsibility of the billing party. Please direct any questions regarding coding to the payer being billed.

Notes
METHODOLOGY: Real time PCR-Qiagen Rotor Gene Q MDx






© 1996 - 2017 Quest Diagnostics Nichols Institute of Valencia
For test information, please call Client Services at 800-421-4449.

San Francisco Web Design & Database